메뉴 건너뛰기




Volumn 73, Issue 2, 2014, Pages 249-257

A phase I trial of flavopiridol in relapsed multiple myeloma

Author keywords

Cyclin dependent kinase inhibitor; Flavopiridol; Multiple myeloma; Pharmacokinetics; Phase 1 clinical trial

Indexed keywords

CYCLIN D1; FLAVOPIRIDOL; RETINOBLASTOMA PROTEIN;

EID: 84896040809     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2347-y     Document Type: Article
Times cited : (35)

References (30)
  • 1
    • 22044440425 scopus 로고    scopus 로고
    • Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma
    • DOI 10.1182/blood-2005-01-0034
    • Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106:296-303 (Pubitemid 40967205)
    • (2005) Blood , vol.106 , Issue.1 , pp. 296-303
    • Bergsagel, P.L.1    Kuehl, W.M.2    Zhan, F.3    Sawyer, J.4    Barlogie, B.5    Shaughnessy Jr., J.6
  • 4
    • 0035943710 scopus 로고    scopus 로고
    • Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo
    • Chao SH, Price DH (2001) Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 276:31793-31799
    • (2001) J Biol Chem , vol.276 , pp. 31793-31799
    • Chao, S.H.1    Price, D.H.2
  • 5
    • 0035835827 scopus 로고    scopus 로고
    • p107 and p130: Versatile proteins with interesting pockets
    • DOI 10.1006/excr.2000.5135
    • Classon M, Dyson N (2001) p107 and p130: versatile proteins with interesting pockets. Exp Cell Res 264:135-147 (Pubitemid 32989088)
    • (2001) Experimental Cell Research , vol.264 , Issue.1 , pp. 135-147
    • Classon, M.1    Dyson, N.2
  • 6
    • 18344383345 scopus 로고    scopus 로고
    • Pocket proteins and cell cycle control
    • Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24:2796-2809
    • (2005) Oncogene , vol.24 , pp. 2796-2809
    • Cobrinik, D.1
  • 7
    • 33645231619 scopus 로고    scopus 로고
    • Cyclin D1 overexpression increases the susceptibility of human U266 myeloma cells to CDK inhibitors through a process involving p130-, p107- and E2F-dependent S phase entry
    • Dai Y, Hamm TE, Dent P, Grant S (2006) Cyclin D1 overexpression increases the susceptibility of human U266 myeloma cells to CDK inhibitors through a process involving p130-, p107- and E2F-dependent S phase entry. Cell Cycle 5:437-446
    • (2006) Cell Cycle , vol.5 , pp. 437-446
    • Dai, Y.1    Hamm, T.E.2    Dent, P.3    Grant, S.4
  • 12
    • 0036850211 scopus 로고    scopus 로고
    • The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1
    • Gojo I, Zhang B, Fenton RG (2002) The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Clin Cancer Res 8:3527-3538 (Pubitemid 35340731)
    • (2002) Clinical Cancer Research , vol.8 , Issue.11 , pp. 3527-3538
    • Gojo, I.1    Zhang, B.2    Fenton, R.G.3
  • 19
    • 9244239811 scopus 로고    scopus 로고
    • G1 cell-cycle control and cancer
    • Massague J (2004) G1 cell-cycle control and cancer. Nature 432:298-306
    • (2004) Nature , vol.432 , pp. 298-306
    • Massague, J.1
  • 22
    • 44449083839 scopus 로고    scopus 로고
    • Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule
    • Phelps MA, Rozewski DM, Johnston JS, Farley KL, Albanese KA, Byrd JC, Lin TS, Grever MR, Dalton JT (2008) Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule. J Chromatogr B Analyt Technol Biomed Life Sci 868:110-115
    • (2008) J Chromatogr B Analyt Technol Biomed Life Sci , vol.868 , pp. 110-115
    • Phelps, M.A.1    Rozewski, D.M.2    Johnston, J.S.3    Farley, K.L.4    Albanese, K.A.5    Byrd, J.C.6    Lin, T.S.7    Grever, M.R.8    Dalton, J.T.9
  • 24
    • 0036138680 scopus 로고    scopus 로고
    • Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol
    • DOI 10.1016/S0145-2126(01)00103-5, PII S0145212601001035
    • Semenov I, Akyuz C, Roginskaya V, Chauhan D, Corey SJ (2002) Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol. Leuk Res 26:271-280 (Pubitemid 34037024)
    • (2002) Leukemia Research , vol.26 , Issue.3 , pp. 271-280
    • Semenov, I.1    Akyuz, C.2    Roginskaya, V.3    Chauhan, D.4    Corey, S.J.5
  • 26
    • 0029849620 scopus 로고    scopus 로고
    • Cancer cell cycles
    • Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
    • (1996) Science , vol.274 , pp. 1672-1677
    • Sherr, C.J.1
  • 28
    • 1042278138 scopus 로고    scopus 로고
    • Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation. Abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9
    • DOI 10.1074/jbc.M304546200
    • Takada Y, Aggarwal BB (2004) Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem 279:4750-4759 (Pubitemid 38199070)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.6 , pp. 4750-4759
    • Takada, Y.1    Aggarwal, B.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.